| Name | Title | Contact Details |
|---|
Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide. Acucela currently has the following candidates in development with Otsuka Pharmaceutical: emixustat hydrochloride for GA associated with dry AMD based on Acucela’s proprietary visual cycle modulation; and OPA-6566 for ocular hypertension and glaucoma.
Whole Hog Productions is a Milwaukee, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Rochester Electro-Medical is a Tampa, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
A leading specialty formulator and contract manufacturer of enzyme and probiotic-based dietary supplements.
InterMune, Inc. (InterMune) is a biotech company focused on developing and commercializing therapies in pulmonology and hepatology.